Clinical Trial Update: Evaluation of KX2-391 in Patients With Advanced Malignancies [Phase 1]

View source ↗

Summary

This entry reports completion of a Phase 1 trial evaluating KX2-391 in patients with advanced solid tumors and lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• KX2-391

Snippet

Sponsor: Athenex, Inc. | Conditions: Solid Tumors, Lymphoma | Phase 1 | Status: COMPLETED